Arcus Biosciences IncNYSE:RCUS
- LAST PRICE15.8100
- TODAY'S CHANGE (%)0.8300 (5.5407%)
- Bid / Lots15.5000/ 1
- Ask / Lots16.8400/ 12
- Open / Previous Close15.3300 / 14.9800
- Day Range
- 52 Week Range
- Volume433,942
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RCUS |
|---|---|---|
| 09:32 ET | 4431 | 15.08 |
| 09:34 ET | 2300 | 15.2 |
| 09:36 ET | 3168 | 15.29 |
| 09:38 ET | 100 | 15.29 |
| 09:39 ET | 400 | 15.425 |
| 09:41 ET | 1700 | 15.2788 |
| 09:45 ET | 210 | 15.39 |
| 09:48 ET | 100 | 15.415 |
| 09:50 ET | 100 | 15.4 |
| 09:52 ET | 3529 | 15.385 |
| 09:54 ET | 2568 | 15.55 |
| 09:56 ET | 1071 | 15.53 |
| 09:57 ET | 100 | 15.53 |
| 09:59 ET | 1601 | 15.505 |
| 10:01 ET | 926 | 15.56 |
| 10:03 ET | 998 | 15.565 |
| 10:06 ET | 204 | 15.565 |
| 10:08 ET | 1468 | 15.51 |
| 10:10 ET | 300 | 15.39 |
| 10:12 ET | 1000 | 15.381 |
| 10:14 ET | 972 | 15.365 |
| 10:15 ET | 2070 | 15.42 |
| 10:19 ET | 300 | 15.395 |
| 10:21 ET | 732 | 15.36 |
| 10:24 ET | 334 | 15.35 |
| 10:26 ET | 450 | 15.3652 |
| 10:28 ET | 100 | 15.38 |
| 10:30 ET | 120 | 15.36 |
| 10:32 ET | 1090 | 15.27 |
| 10:33 ET | 1391 | 15.27 |
| 10:35 ET | 500 | 15.32 |
| 10:37 ET | 300 | 15.315 |
| 10:39 ET | 100 | 15.315 |
| 10:42 ET | 2360 | 15.44 |
| 10:44 ET | 200 | 15.425 |
| 10:48 ET | 300 | 15.39 |
| 10:50 ET | 400 | 15.38 |
| 10:53 ET | 100 | 15.325 |
| 10:55 ET | 110 | 15.32 |
| 11:00 ET | 473 | 15.34 |
| 11:04 ET | 1218 | 15.34 |
| 11:06 ET | 614 | 15.335 |
| 11:08 ET | 100 | 15.34 |
| 11:09 ET | 400 | 15.36 |
| 11:13 ET | 609 | 15.345 |
| 11:15 ET | 367 | 15.315 |
| 11:18 ET | 100 | 15.3 |
| 11:20 ET | 100 | 15.31 |
| 11:22 ET | 908 | 15.3 |
| 11:27 ET | 209 | 15.32 |
| 11:31 ET | 914 | 15.34 |
| 11:33 ET | 100 | 15.33 |
| 11:36 ET | 206 | 15.33 |
| 11:42 ET | 200 | 15.365 |
| 11:44 ET | 120 | 15.35 |
| 11:45 ET | 100 | 15.365 |
| 11:47 ET | 464 | 15.37 |
| 11:51 ET | 410 | 15.37 |
| 11:54 ET | 1100 | 15.39 |
| 11:56 ET | 2588 | 15.35 |
| 11:58 ET | 238 | 15.36 |
| 12:00 ET | 416 | 15.39 |
| 12:03 ET | 300 | 15.42 |
| 12:05 ET | 370 | 15.445 |
| 12:09 ET | 850 | 15.42 |
| 12:12 ET | 100 | 15.445 |
| 12:14 ET | 400 | 15.435 |
| 12:16 ET | 873 | 15.43 |
| 12:18 ET | 287 | 15.4521 |
| 12:20 ET | 100 | 15.435 |
| 12:21 ET | 812 | 15.4 |
| 12:23 ET | 200 | 15.395 |
| 12:25 ET | 300 | 15.39 |
| 12:30 ET | 100 | 15.39 |
| 12:32 ET | 1384 | 15.3701 |
| 12:34 ET | 1443 | 15.36 |
| 12:36 ET | 1621 | 15.34 |
| 12:39 ET | 133 | 15.34 |
| 12:41 ET | 300 | 15.41 |
| 12:43 ET | 200 | 15.4 |
| 12:45 ET | 800 | 15.41 |
| 12:48 ET | 100 | 15.41 |
| 12:50 ET | 1208 | 15.34 |
| 12:52 ET | 197 | 15.36 |
| 12:54 ET | 100 | 15.34 |
| 12:56 ET | 601 | 15.34 |
| 12:59 ET | 529 | 15.345 |
| 01:01 ET | 100 | 15.35 |
| 01:03 ET | 4540 | 15.45 |
| 01:06 ET | 300 | 15.44 |
| 01:08 ET | 100 | 15.45 |
| 01:10 ET | 886 | 15.44 |
| 01:12 ET | 100 | 15.43 |
| 01:14 ET | 951 | 15.45 |
| 01:17 ET | 450 | 15.42 |
| 01:24 ET | 455 | 15.41 |
| 01:26 ET | 304 | 15.44 |
| 01:28 ET | 100 | 15.45 |
| 01:30 ET | 300 | 15.45 |
| 01:33 ET | 903 | 15.4965 |
| 01:35 ET | 2857 | 15.415 |
| 01:37 ET | 310 | 15.42 |
| 01:42 ET | 530 | 15.47 |
| 01:46 ET | 3800 | 15.5 |
| 01:48 ET | 545 | 15.59 |
| 01:50 ET | 422 | 15.54 |
| 01:51 ET | 1100 | 15.5335 |
| 01:55 ET | 200 | 15.56 |
| 02:00 ET | 127 | 15.54 |
| 02:04 ET | 1050 | 15.55 |
| 02:06 ET | 537 | 15.56 |
| 02:09 ET | 200 | 15.545 |
| 02:11 ET | 600 | 15.56 |
| 02:15 ET | 707 | 15.54 |
| 02:18 ET | 3897 | 15.58 |
| 02:20 ET | 1011 | 15.565 |
| 02:22 ET | 1750 | 15.58 |
| 02:24 ET | 400 | 15.58 |
| 02:26 ET | 2685 | 15.59 |
| 02:27 ET | 17500 | 15.69 |
| 02:29 ET | 200 | 15.69 |
| 02:31 ET | 1893 | 15.67 |
| 02:33 ET | 265 | 15.655 |
| 02:38 ET | 304 | 15.68 |
| 02:42 ET | 870 | 15.66 |
| 02:44 ET | 100 | 15.65 |
| 02:45 ET | 500 | 15.67 |
| 02:47 ET | 200 | 15.665 |
| 02:51 ET | 1200 | 15.7 |
| 02:56 ET | 400 | 15.65 |
| 02:58 ET | 1003 | 15.68 |
| 03:00 ET | 500 | 15.66 |
| 03:02 ET | 2367 | 15.66 |
| 03:03 ET | 200 | 15.67 |
| 03:05 ET | 948 | 15.65 |
| 03:07 ET | 640 | 15.64 |
| 03:09 ET | 1528 | 15.66 |
| 03:12 ET | 3682 | 15.75 |
| 03:14 ET | 114 | 15.7452 |
| 03:16 ET | 300 | 15.735 |
| 03:18 ET | 100 | 15.75 |
| 03:20 ET | 360 | 15.74 |
| 03:21 ET | 3283 | 15.79 |
| 03:23 ET | 6171 | 15.8 |
| 03:25 ET | 3619 | 15.84 |
| 03:27 ET | 4596 | 15.82 |
| 03:30 ET | 600 | 15.8 |
| 03:32 ET | 520 | 15.75 |
| 03:34 ET | 1089 | 15.711 |
| 03:36 ET | 2651 | 15.69 |
| 03:38 ET | 3067 | 15.75 |
| 03:39 ET | 1899 | 15.79 |
| 03:41 ET | 700 | 15.81 |
| 03:43 ET | 1200 | 15.815 |
| 03:45 ET | 3506 | 15.85 |
| 03:48 ET | 6777 | 15.875 |
| 03:50 ET | 4310 | 15.89 |
| 03:52 ET | 6368 | 15.885 |
| 03:54 ET | 8237 | 15.82 |
| 03:56 ET | 4957 | 15.81 |
| 03:57 ET | 8836 | 15.84 |
| 03:59 ET | 20316 | 15.81 |
Yesterday
Press Release: Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update, from 5:34PM ET on Thursday Jul 25, 2024 by Dow Jones
5:34PM ET on Thursday Jul 25, 2024 by Dow JonesArcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update, from 4:05PM ET on Thursday Jul 25, 2024 by Dow Jones
4:05PM ET on Thursday Jul 25, 2024 by Dow Jones
Jul 9, 2024
Arcus Biosciences Announces New Employment Inducement Grants, from 4:35PM ET on Tuesday Jul 09, 2024 by Dow Jones
4:35PM ET on Tuesday Jul 09, 2024 by Dow Jones
Jul 8, 2024
Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia, from 6:00PM ET on Monday Jul 08, 2024 by Dow Jones
6:00PM ET on Monday Jul 08, 2024 by Dow JonesDJ Arcus Biosciences Is Maintained at Overweight by Barclays, from 4:09PM ET on Monday Jul 08, 2024 by Dow Jones
4:09PM ET on Monday Jul 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcus Biosciences Inc | 1.4B | -5.1x | --- |
Gyre Therapeutics Inc | 1.3B | -8.0x | --- |
Ardelyx Inc | 1.3B | -19.5x | --- |
Prothena Corporation PLC | 1.3B | -7.5x | --- |
Nurix Therapeutics Inc | 1.4B | -7.5x | --- |
Vir Biotechnology Inc | 1.5B | -2.7x | --- |
Company Information
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Contact Information
- Headquarters
- 3928 Point Eden WayHAYWARD, CA, United States 94545-3719
- Phone
- 510-694-6200
- Fax
- 302-730-1370
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Terry Rosen
- President, Co-Founder
- Juan Jaen
- Chief Financial Officer
- Robert Goeltz
- Chief Operating Officer
- Jennifer Jarrett
- General Counsel
- Carolyn Tang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $237.0M |
Shares Outstanding | 91.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.90 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.1x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -113.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
